Logotype for International Cement Group Ltd

International Cement Group (KUO) AGM presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for International Cement Group Ltd

AGM presentation summary

2 Nov, 2026

Business footprint and competitive position

  • Annual production capacity of 5.5 million tonnes, with operations across Central Asia and cement production in Kazakhstan and Tajikistan.

  • Facilities include Mohir cement plant (1.2mt), Alacem cement plant (1.2mt), Sharcem cement plant (1.0mt), Korcem cement plant (1.5mt), Mohir grinding station (0.6mt) and a gypsum plasterboard plant (30 million sqm).

  • Plants are positioned near markets and resources, including Dushanbe and Almaty; government partnerships include Kazakhstan’s G4 City project.

  • A third Kazakhstan plant added 1.5mt of annual capacity in November 2024, establishing the largest dry-process cement producer in Kazakhstan.

FY2025 financial and operational highlights

  • Korcem completed its first full year of operation; exports began to Kyrgyzstan, and Sharcem recorded its first profitable year after improving production yields and revenue.

  • Revenue from continuing operations rose 47% to S$378.8m; net profit increased more than 29-fold to S$75.2m.

  • Net cash from operating activities increased 62% to S$104.6m, supporting reinvestment, debt reduction and balance-sheet strength.

  • Cement sales volume reached 4.73m tonnes in 2025; revenue five-year CAGR was 20.21%.

  • FY2025 EBITDA was S$122.3m; net profit was S$75.2m.

Cash flow and balance sheet

  • FY2025 net cash from operating activities was S$104.578m; net cash used in investing activities was S$66.677m and net cash used in financing activities was S$30.931m.

  • Cash and cash equivalents were S$12.338m at FY2025 year-end.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from International Cement Group